YURVAC® RHD

Les informations contenues sur ce site Web mondial de HIPRA ne sont pas destinées à être consultées dans tous les pays.

Les informations générales, scientifiques ou techniques sur les produits ou services HIPRA ne sont pas destinées à la promotion commerciale.

Pour obtenir des informations spécifiques sur les produits ou services disponibles dans votre pays, veuillez filtrer par pays correspondant.

Choisissez votre pays

Vaccins

Lapins

YURVAC® RHD

Vaccin recombinant contre la maladie hémorragique virale du lapin (RHD) causée par les souches classiques (RHDV) et variantes (RHDV2), notamment les souches très virulentes, dans une émulsion injectable

Voir la fiche technique du produit

Publications apparentées

Last News

Discover our latest news

YURVAC® RHD

Université HIPRA

HIPRA Diagnos

Maladie hémorragique du lapin (RHD)

Myxomatose

Publications apparentées

YURVAC® RHD vaccine against RHDV and RHDV2

Safety assessment of a single and a repeated dose administration of YURVAC RHD vaccine in dwarf pet rabbits

Lack of interference after simultaneous administration of a live vaccine against myxomatosis and a new recombinant vaccine against rabbit haemorrhagic disease

Efficacy of YURVAC RHD vaccine against RHDV2 strain in the presence or absence of maternally derived antibodies

Rabbit Hemorrhagic Disease (RHD) in six indoor pet rabbits diagnosed in the same week in Portugal: a case series

Effect of vaccination on protection against RHDV-2 and viral load

Efficacy of ERAVAC® against a heterologous challenge with a virulent RHDV-2 strain in the presence and/or absence of maternal derived antibodies

Characterization of the Maternally Derived Antibody Immunity against Rhdv-2

Safety assessment of a single and a repeated dose administration of the inactivated vaccine ERAVAC® in dwarf pet rabbits

Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Efficacy and safety of a new inactivated vaccine against the rabbit haemorrhagic disease virus 2-like variant (RHDV-2)

Temporal evolution of rabbit haemorrhagic disease virus (RHDV) and impact of vaccination during the RHD epidemic in Spain (2013-2015)

Last news

HIPRA demonstrates the extraordinary benefits of YURVAC® RHD at the 13th WRC

HIPRA Portugal presents the new vaccine against RHD

HIPRA PORTUGAL organized the "III Rabbits Farming Meeting"

HIPRA provides a 360º perspective on RHDV during workshops organized in Portugal

HIPRA opts for eco-friendly packaging for all its monodose animal health vaccines

Switch off the non-rational use of antibiotics

Nous nous sommes adaptés pour être plus forts

We organised 7 webinars focussing on rabbit haemorrhagic disease type 2 (RHDV2)

YURVAC® RHD

Services apparentés

Maladies apparentées

Publications apparentées

Last news